Logo image of MPW

MEDICAL PROPERTIES TRUST INC (MPW) Stock Fundamental Analysis

NYSE:MPW - New York Stock Exchange, Inc. - US58463J3041 - REIT - Currency: USD

5.255  +0.01 (+0.29%)

Fundamental Rating

3

MPW gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. MPW may be in some trouble as it scores bad on both profitability and health. MPW does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MPW had negative earnings in the past year.
MPW had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MPW reported negative net income in multiple years.
MPW had a positive operating cash flow in each of the past 5 years.
MPW Yearly Net Income VS EBIT VS OCF VS FCFMPW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

MPW has a worse Return On Assets (-16.87%) than 95.35% of its industry peers.
Looking at the Return On Equity, with a value of -49.89%, MPW is doing worse than 93.80% of the companies in the same industry.
The Return On Invested Capital of MPW (2.23%) is worse than 61.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MPW is in line with the industry average of 3.17%.
Industry RankSector Rank
ROA -16.87%
ROE -49.89%
ROIC 2.23%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
MPW Yearly ROA, ROE, ROICMPW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Operating Margin of MPW (38.86%) is better than 85.27% of its industry peers.
MPW's Operating Margin has declined in the last couple of years.
MPW has a better Gross Margin (97.26%) than 97.67% of its industry peers.
MPW's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.86%
PM (TTM) N/A
GM 97.26%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
MPW Yearly Profit, Operating, Gross MarginsMPW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

2

2. Health

2.1 Basic Checks

MPW has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MPW has more shares outstanding
MPW has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MPW has a worse debt to assets ratio.
MPW Yearly Shares OutstandingMPW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
MPW Yearly Total Debt VS Total AssetsMPW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

MPW has an Altman-Z score of 0.04. This is a bad value and indicates that MPW is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.04, MPW is doing worse than 74.42% of the companies in the same industry.
MPW has a debt to FCF ratio of 147.28. This is a negative value and a sign of low solvency as MPW would need 147.28 years to pay back of all of its debts.
MPW has a Debt to FCF ratio of 147.28. This is comparable to the rest of the industry: MPW outperforms 48.06% of its industry peers.
A Debt/Equity ratio of 1.83 is on the high side and indicates that MPW has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.83, MPW is doing worse than 68.99% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.83
Debt/FCF 147.28
Altman-Z 0.04
ROIC/WACC0.34
WACC6.47%
MPW Yearly LT Debt VS Equity VS FCFMPW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

MPW has a Current Ratio of 1.77. This is a normal value and indicates that MPW is financially healthy and should not expect problems in meeting its short term obligations.
MPW's Current ratio of 1.77 is fine compared to the rest of the industry. MPW outperforms 72.87% of its industry peers.
MPW has a Quick Ratio of 1.77. This is a normal value and indicates that MPW is financially healthy and should not expect problems in meeting its short term obligations.
MPW has a Quick ratio of 1.77. This is in the better half of the industry: MPW outperforms 72.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.77
MPW Yearly Current Assets VS Current LiabilitesMPW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

MPW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1156.52%.
MPW shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.56%.
The Revenue has been growing slightly by 3.11% on average over the past years.
EPS 1Y (TTM)-1156.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)19.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%-17.51%

3.2 Future

MPW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.12% yearly.
The Revenue is expected to decrease by -0.37% on average over the next years.
EPS Next Y97.39%
EPS Next 2Y41.01%
EPS Next 3Y28.12%
EPS Next 5YN/A
Revenue Next Year-3.22%
Revenue Next 2Y0.84%
Revenue Next 3Y4.28%
Revenue Next 5Y-0.37%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MPW Yearly Revenue VS EstimatesMPW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
MPW Yearly EPS VS EstimatesMPW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MPW. In the last year negative earnings were reported.
Also next year MPW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MPW Price Earnings VS Forward Price EarningsMPW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100 -100 -150

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MPW is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MPW is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 52.65
EV/EBITDA 13.88
MPW Per share dataMPW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as MPW's earnings are expected to grow with 28.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.01%
EPS Next 3Y28.12%

4

5. Dividend

5.1 Amount

MPW has a Yearly Dividend Yield of 6.11%, which is a nice return.
Compared to an average industry Dividend Yield of 6.65, MPW has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.45, MPW pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.11%

5.2 History

The dividend of MPW decreases each year by -10.38%.
MPW has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-10.38%
Div Incr Years0
Div Non Decr Years0
MPW Yearly Dividends per shareMPW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of MPW are negative and hence is the payout ratio. MPW will probably not be able to sustain this dividend level.
DP-13.32%
EPS Next 2Y41.01%
EPS Next 3Y28.12%
MPW Yearly Income VS Free CF VS DividendMPW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

MEDICAL PROPERTIES TRUST INC

NYSE:MPW (5/5/2025, 10:54:47 AM)

5.255

+0.01 (+0.29%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners62.86%
Inst Owner Change-1.16%
Ins Owners16.95%
Ins Owner Change11.47%
Market Cap3.16B
Analysts52.22
Price Target5.69 (8.28%)
Short Float %33.09%
Short Ratio14.59
Dividend
Industry RankSector Rank
Dividend Yield 6.11%
Yearly Dividend0.54
Dividend Growth(5Y)-10.38%
DP-13.32%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-10 2025-03-10 (0.08)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1791.73%
Min EPS beat(2)-2512.24%
Max EPS beat(2)-1071.21%
EPS beat(4)0
Avg EPS beat(4)-1105.79%
Min EPS beat(4)-2512.24%
Max EPS beat(4)-186.63%
EPS beat(8)1
Avg EPS beat(8)-512.17%
EPS beat(12)4
Avg EPS beat(12)-334.55%
EPS beat(16)7
Avg EPS beat(16)-251.96%
Revenue beat(2)1
Avg Revenue beat(2)-2.03%
Min Revenue beat(2)-9.56%
Max Revenue beat(2)5.51%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-9.56%
Max Revenue beat(4)5.9%
Revenue beat(8)3
Avg Revenue beat(8)-1.06%
Revenue beat(12)4
Avg Revenue beat(12)-1.71%
Revenue beat(16)7
Avg Revenue beat(16)-0.82%
PT rev (1m)5.1%
PT rev (3m)22.37%
EPS NQ rev (1m)93.32%
EPS NQ rev (3m)94.99%
EPS NY rev (1m)6.82%
EPS NY rev (3m)-60.78%
Revenue NQ rev (1m)1.75%
Revenue NQ rev (3m)4.52%
Revenue NY rev (1m)1.83%
Revenue NY rev (3m)4.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.18
P/FCF 52.65
P/OCF 12.89
P/B 0.65
P/tB 0.65
EV/EBITDA 13.88
EPS(TTM)-2.43
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)0.1
FCFY1.9%
OCF(TTM)0.41
OCFY7.76%
SpS1.65
BVpS8.03
TBVpS8.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.87%
ROE -49.89%
ROCE 2.82%
ROIC 2.23%
ROICexc 2.28%
ROICexgc 2.36%
OM 38.86%
PM (TTM) N/A
GM 97.26%
FCFM 6.03%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
ROICexc(3y)2.3%
ROICexc(5y)3.06%
ROICexgc(3y)2.37%
ROICexgc(5y)3.14%
ROCE(3y)2.86%
ROCE(5y)3.79%
ROICexcg growth 3Y-18.25%
ROICexcg growth 5Y-8.72%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-8.92%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 1.83
Debt/FCF 147.28
Debt/EBITDA 10.53
Cap/Depr 40.86%
Cap/Sales 18.62%
Interest Coverage 0.92
Cash Conversion 29.2%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.77
Altman-Z 0.04
F-Score5
WACC6.47%
ROIC/WACC0.34
Cap/Depr(3y)171.64%
Cap/Depr(5y)740.47%
Cap/Sales(3y)50.73%
Cap/Sales(5y)169.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1156.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y97.39%
EPS Next 2Y41.01%
EPS Next 3Y28.12%
EPS Next 5YN/A
Revenue 1Y (TTM)19.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%-17.51%
Revenue Next Year-3.22%
Revenue Next 2Y0.84%
Revenue Next 3Y4.28%
Revenue Next 5Y-0.37%
EBIT growth 1Y375.98%
EBIT growth 3Y-28.05%
EBIT growth 5Y-7.83%
EBIT Next Year118.92%
EBIT Next 3Y38.21%
EBIT Next 5YN/A
FCF growth 1Y-61.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.46%
OCF growth 3Y-32.88%
OCF growth 5Y-13.06%